Martha Bebinger
-
Some physicians say connecting environmental effects of climate change — heat waves, more pollen and longer allergy seasons — to the health consequences helps them better care for patients.
-
A study looked at who gets prescriptions for buprenorphine, and found that white patients are almost 35 times as likely to get the lifesaving addiction treatment than African Americans.
-
The maker of OxyContin will pay to settle a historic opioid lawsuit brought by the attorney general of Oklahoma. Will other drugmakers named in the lawsuit follow?
-
Overdose deaths involving fentanyl are rising — up 113 percent on average each year from 2013 to 2016. Dealers are adding cheap fentanyl to the illicit drug supply, and some users get it accidentally.
-
The Massachusetts attorney general alleges that the family behind Purdue Pharma knew that OxyContin was causing overdoses, yet continued to cash in. New documents in the case were released Thursday.
-
In a detailed memorandum, Attorney General Maura Healey alleges eight Sackler family members and nine Purdue board members or executives played key roles in the nation's deadly opioid epidemic.
-
The U.S. surgeon general has called on "bystanders" to be equipped with the opioid reversal drug to save lives. But when a nurse answered that call, her application for life insurance was denied. Why?
-
The overdose antidote naloxone could soon be available in more public places. The Veterans Administration is adding it to its automated defibrillator cabinets. Other institutions are following suit.
-
Massachusetts planned to exclude expensive drugs that weren't proven to work better than existing alternatives from its Medicaid plan. Medicaid drug spending had doubled in five years.
-
One big question in Supreme Court confirmation hearings of Judge Brett Kavanaugh is how he would rule on a challenge to Roe v. Wade. A rejection could give states first say in abortion regulation.